Picture of Foghorn Therapeutics logo

FHTX — Foghorn Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Foghorn Therapeutics Q3 EPS USD -0.31

Nov 04 (Reuters) - Foghorn Therapeutics Q3 collaboration revenue USD 7.808
million.
* Q3 net income USD -19.122 million

Recent news on Foghorn Therapeutics

See all news